Histone Deacetylase Inhibitor Potentiates Anticancer Effect of Docetaxel via Modulation of Bcl-2 Family Proteins and Tubulin in Hormone Refractory Prostate Cancer Cells
Keywords: هیستون deacetylases; prostate; prostatic neoplasms; histone deacetylases; docetaxel; apoptosisCI, combination index; HDAC, histone deacetylase; HDACI, HDAC inhibitor; HRPC, hormone refractory prostate cancer; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-s